Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin's lymphoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 36, 2006, Pages 13485-13490

  Meredith, Elizabeth J ^a   Holder, Michelle J ^a   Rosén, Anders ^b   Lee, Adrian Drake ^c   Dyer, Martin J S ^d   Barnes, Nicholas M ^a   Gordon, John ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Apoptosis; Bcl 2; Monoamines; Oxidative stress; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT; APOMORPHINE; CATALASE; CATECHOLAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; HYDROGEN PEROXIDE; INHIBITOR OF APOPTOSIS PROTEIN; LEVODOPA; PROTEIN BCL 2; THIOREDOXIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CLONE; CELL POPULATION; CONTROLLED STUDY; CYTOSTASIS; EXPOSURE; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; NONHODGKIN LYMPHOMA; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; B-LYMPHOCYTES; CATALASE; CELL LINE; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HERPESVIRUS 4, HUMAN; HUMANS; HYDROGEN PEROXIDE; LYMPHOMA, NON-HODGKIN; MEMBRANE TRANSPORT PROTEINS; OXIDANTS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, DOPAMINE;

EID: 33748622833     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0605993103     Document Type: Article

References (48)

1. Ansell, S. & Armitage, J. (2005) Mayo Clin. Proc. 80, 1087-1097.
2. Traulle, C. & Coiffier, B. (2005) Future Oncol. 1, 297-306.
3. Maher, E. & Fine, H. (1999) Semin. Oncol. 26, 346-356.
4. Navarro, W. H. & Kaplan, L. D. (2006) Blood 107, 13-20.
5. Spina, M., Simonelli, C., Talamini, R. & Tirelli, U. (2005) J. Clin. Oncol. 23, 8132-8133.
6. Hesseling, P., Broadhead, R., Mansvelt, E., Louw, M., Wessels, G., Borgstein, E., Schneider, J. & Molyneux, E. (2005) Pediatr. Blood Cancer 44, 245-250.
7. Lavu, E., Morewaya, J., Maraka, R., Kiromat, M., Ripa, P. & Vince, J. (2005) Ann. Trop. Paediatr. 25, 191-197.
8. Meinl, E., Krumbholz, M. & Hohlfeld, R. (2006) Ann. Neurol. 59, 880-892.
9. O'Connell, P., Wang, X., Leon-Ponte, M., Griffiths, C., Pingle, S. & Ahern, G. (2006) Blood 107, 1010-1017.
10. Straub, R. (2004) Trends Pharmacol. Sci. 25, 640-646.
11. Meredith, E., Holder, M., Chamba, A., Challa, A., Drake-Lee, A., Bunce, C., Drayson, M., Pilkington, G., Blakely, R., Dyer, M. J., et al. (2005) FASEB J. 19, 1187-1189.
12. Serafeim, A., Grafton, G., Chamba, A., Gregory, C. D., Blakely, R. D., Bowery, N. G., Barnes, N. M. & Gordon, J. (2002) Blood 99, 2545-2553.
13. Serafeim, A., Holder, M. J., Grafton, G., Chamba, A., Drayson, M. T., Luong, Q. T., Bunce, C. M., Gregory, C. D., Barnes, N. M. & Gordon, J. (2003) Blood 101, 3212-3219.
14. Gordon, J. & Barnes, N. (2003) Trends Immunol. 24, 438-443.
15. Meredith, E., Chamba, A., Holder, M., Barnes, N. & Gordon, J. (2005) Immunology 115, 289-295.
16. Johnston, T., Fox, S. & Brotchie, J. (2005) Expert Opin. Drug Delivery 2, 1059-1073.
17. Liu, Y., Mason, D., Johnson, G., Abbot, S., Gregory, C., Hardie, D., Gordon, J. & MacLennan, I. (1991) Eur. J. Immunol. 21, 1905-1910.
18. Matsuzaki, H., Hata, H., Asou, N., Suzushima, H., Akahoshi, Y., Yoshida, M., Nagakura, S., Ishii, T., Sanada, I. & Takatsuki, K. (1990) Acta. Haematol. 84, 156-161.
19. Andersen, P. (1989) Eur. J. Pharmacol. 166, 493-504.
20. Civelli, O. & Zhou, Q. (2001) in Encyclopedia of Life Sciences (Wiley, Chichester, U.K.), Vol. 2006.
21. Heikkila, R., Babington, R. & Houlihan, W. (1981) Eur. J. Pharmacol. 71, 277-286.
22. Roth, B., Lopez, E., Patel, S. & Kroeze, W. (2000) Neuroscientist 6, 252-262.
23. Slominski, A., Paus, R. & Mihm, M. (1998) Anticancer Res. 18, 3709-3715.
24. Slominski, A., Tobin, D., Shibahara, S. & Wortsman, J. (2004) Physiol. Rev. 84, 1155-1228.
25. Zhao, K., Zhao, G., Wu, D., Soong, Y., Birk, A., Schiller, P. & Szeto, H. (2004) J. Biol. Chem. 279, 34682-34690.
26. Clement, M., Long, L. H., Ramalingam, J. & Halliwell, B. (2002) J. Neurochem. 81, 414-421.
27. Kim, J., Kwon, K., Yoon, H., Lee, S. & Rhee, S. (2002) Arch. Biochem. Biophys. 397, 414-423.
28. Lotharius, J. & O'Malley, K. (2000) J. Biol. Chem. 275, 38581-38588.
29. Nilsson, J., Soderberg, O., Nilsson, K. & Rosen, A. (2000) Blood 95, 1420-1426.
30. Berggren, M., Husbeck, B., Samulitis, B., Baker, A., Gallegos, A. & Powis, G. (2001) Arch. Biochem. Biophys. 392, 103-109.
31. Jang, J. & Surh, Y. (2003) Biochem. Pharmacol. 66, 1371-1379.
32. Korsmeyer, S., Shutter, J., Veis, D., Merry, D. & Oltvai, Z. (1993) Semin. Cancer Biol. 4, 327-332.
33. Lee, Y. & Shacter, E. (1997) Blood 89, 4480-4492.
34. Hampton, M. & Orrenius, S. (1997) FEBS Lett 414, 552-556.
35. Chen, Q., Espey, M. G., Krishna, M. C., Mitchell, J. B., Corpe, C. P., Buettner, G. R., Shacter, E. & Levine, M. (2005) Proc. Natl. Acad. Sci. USA 102, 13604-13609.
36. Slominski, A. & Goodman-Snitkoff, G. (1992) Anticancer Res. 12, 753-756.
37. Takahashi, A., Hanson, M., Norell, H., Havelka, A., Kono, K., Malmberg, K. & Kiessling, R. (2005) J. Immunol. 174, 6080-6087.
38. Bergquist, J., Tarkowski, A., Ewing, A. & Ekman, R. (1998) Immunol. Today 19, 562-567.
39. Bergquist, J., Josefsson, E., Tarkowski, A., Ekman, R. & Ewing, A. (1997) Electrophoresis 18, 1760-1766.
40. Bergquist, J., Ohlsson, B. & Tarkowski, A. (2000) Neuroimmunomodulation 917, 281-289.
41. Bergquist, J., Tarkowski, A., Ekman, R. & Ewing, A. (1994) Proc. Natl. Acad. Sci. USA 91, 12912-12916.
42. Rajda, C., Dibo, G., Vecsei, L. & Bergquist, J. (2005) Neuroimmunomodulation 12, 81-84.
43. Di Stefano, A., Carafa, M., Sozio, P., Pinnen, F., Braghiroli, D., Orlando, G., Cannazza, G., Ricciutelli, M., Marianecci, C. & Santucci, E. (2004) J. Control Release 99, 293-300.
44. Sapra, P. & Allen, T. (2004) Clin. Cancer Res. 10, 2530-2537.
45. Jain, N., Rana, A. & Jain, S. (1998) Drug Dev. Ind. Pharm. 24, 671-675.
46. Milner, A., Johnson, G. & Gregory, C. (1992) Int. J. Cancer 52, 636-644.
47. Wang, H., Grand, R., Milner, A., Armitage, R., Gordon, J. & Gregory, C. (1996) Oncogene 13, 373-379.
48. McCloskey, N., Pound, J., Holder, M., Williams, J., Roberts, L., Lord, J. & Gordon, J. (1999) Eur. J. Immunol. 29, 3236-3244.